Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China
- PMID: 12395332
- DOI: 10.1053/jhep.2002.36366
Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China
Abstract
We assessed the separate and combined effects of hepatitis B virus (HBV), hepatitis C virus (HCV), and aflatoxin in causing hepatocellular carcinoma (HCC) in Qidong, China. A consecutive series of 181 pathologic-diagnosed HCC cases were studied for hepatitis B surface antigen (HBsAg), anti-HBc, HBV X gene sequence, anti-HCV, the 249ser-p53 mutation, and chronic hepatitis pathology. Each of the 181 incident HCC cases had markers for HBV infection and hepatitis pathology; only 6 of 119 cases were coinfected with HCV. The 249ser-p53 mutation was found in 54% (97/181) of HCC cases and in all 7 cases with tissue for analysis from the hepatitis cohort but in none of 42 matched cases from Beijing. The estimated cumulative dose of aflatoxin B1 in these 7 cases ranged from 0.13 to 0.49 mg/kg. Follow-up data through 13.25 years on a cohort of 145 men with chronic HBV hepatitis showed that the relative risk from aflatoxin exposure was 3.5 (1.5-8.1). A similar relative risk was found using 249ser-p53 mutation as a marker for aflatoxin exposure. In conclusion, HBV hepatitis is ubiquitous in Qidong HCC cases, whereas HCV contributes little to its risk. The 249ser-p53 mutation appears to result from coexposure to aflatoxin and HBV infection. Even modest levels of aflatoxin exposure tripled the risk of HCC in HBV-infected men.
Comment in
-
Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology.Hepatology. 2002 Nov;36(5):1046-9. doi: 10.1053/jhep.2002.37084. Hepatology. 2002. PMID: 12395312 Review. No abstract available.
Similar articles
-
HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.J Viral Hepat. 2005 May;12(3):325-9. doi: 10.1111/j.1365-2893.2005.00586.x. J Viral Hepat. 2005. PMID: 15850475
-
Tight association of hepatocellular carcinoma with HBV infection in North China.Hepatobiliary Pancreat Dis Int. 2005 Feb;4(1):46-9. Hepatobiliary Pancreat Dis Int. 2005. PMID: 15730918
-
Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):617-25. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11401911
-
Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.Mutat Res. 2008 Jul-Aug;659(1-2):176-84. doi: 10.1016/j.mrrev.2008.01.005. Epub 2008 Jan 20. Mutat Res. 2008. PMID: 18346933 Review.
-
Hepatitis B and C virus-related carcinogenesis.Clin Microbiol Infect. 2009 Nov;15(11):964-70. doi: 10.1111/j.1469-0691.2009.03035.x. Clin Microbiol Infect. 2009. PMID: 19874379 Review.
Cited by
-
Role of p53 suppression in the pathogenesis of hepatocellular carcinoma.World J Gastrointest Pathophysiol. 2023 Jun 1;14(3):46-70. doi: 10.4291/wjgp.v14.i3.46. World J Gastrointest Pathophysiol. 2023. PMID: 37304923 Free PMC article. Review.
-
Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review).Oncol Rep. 2023 Mar;49(3):48. doi: 10.3892/or.2023.8485. Epub 2023 Jan 20. Oncol Rep. 2023. PMID: 36660927 Free PMC article. Review.
-
Alcoholic liver disease in relation to cancer incidence and mortality: Findings from a large, matched cohort study in South Korea.Cancer Med. 2023 Apr;12(7):8754-8766. doi: 10.1002/cam4.5614. Epub 2023 Jan 18. Cancer Med. 2023. PMID: 36653955 Free PMC article.
-
Aflatoxin B1 exposure disrupts the intestinal immune function via a soluble epoxide hydrolase-mediated manner.Ecotoxicol Environ Saf. 2023 Jan 1;249:114417. doi: 10.1016/j.ecoenv.2022.114417. Epub 2022 Dec 14. Ecotoxicol Environ Saf. 2023. PMID: 36525946 Free PMC article.
-
Transgenic zebrafish for modeling hepatocellular carcinoma.MedComm (2020). 2020 Sep 3;1(2):140-156. doi: 10.1002/mco2.29. eCollection 2020 Sep. MedComm (2020). 2020. PMID: 34766114 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous